06 Jun 2011
FREEDOM-M Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint
SILVER SPRING, Md., June 6, 2011 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the completion of its FREEDOM-M Phase 3 trial of treprostinil diethanolamine (oral treprostinil), an...
SILVER SPRING, Md., April 28, 2011 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2011."I'm very pleased that we are cruising at...
SILVER SPRING, Md., April 21, 2011 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2011 financial results before market open on Thursday, April 28...
SILVER SPRING, Md., March 21, 2011 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that enrollment in its FREEDOM-C(2) registration trial was completed on March 18, 2011.FREEDOM-C(2) is a...
15 Feb 2011
United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
SILVER SPRING, Md., Feb. 15, 2011 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2010."We finished 2010 with solid...
SILVER SPRING, Md., Feb. 8, 2011 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its fourth quarter and annual 2010 financial results before market open on Tuesday...
SILVER SPRING, Md., February 2, 2011 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that enrollment in its FREEDOM-M registration trial was completed on January 31, 2011.FREEDOM-M is a...
SILVER SPRING, Md., Oct. 28 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2010.Total revenues for the third quarter...
SILVER SPRING, Md., Oct. 21 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its third quarter 2010 financial results before market open on Thursday, October...
SILVER SPRING, Md., July 28 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended June 30, 2010.Total revenues for the second quarter of...
SILVER SPRING, Md., July 21 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will release its second quarter 2010 financial results before market open on Wednesday, July 28...
01 Jul 2010
United Therapeutics and Lee's Pharmaceutical Sign Remodulin Distribution Agreement for China
SILVER SPRING, Md., July 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) and Lee's Pharmaceutical Holdings Ltd. (HKEx: 0950) announced today that they have entered into an exclusive agreement...